For Specialized Pharmacy and Health Care Legal Services Call (720)222-1276 • Baer Law provides services to all of the United States

Client Focused. Results Driven.

Understanding where pharmacy and law intersect. Expert representation at a reasonable price

Baer Law

25521 E. Smoky Hill Road
Suite #120, Aurora, CO 80016
720.222.1276

Please enter your name.
Please enter a message.
BaerLaw_Color_Logo

About Baer Law

John brings over twenty-five combined years of experience as a pharmacist and attorney to the Baer Law Firm LLC. John's personal goal since finishing law school was to incorporate both his experiences as a clinical pharmacist and an attorney into his own, successful law practice. After obtaining his undergraduate and his Doctorate of Pharmacy (PharmD) degrees from the University of Arizona, John relocated to Colorado. He continued to work as a clinical hospital pharmacist while attending law school and obtained his Juris Doctorate (JD) at the University of Denver College of Law.

Our Legal Services

We are uniquely positioned to understand the complex needs of our diverse clients. 

PharmacyIcon

Pharmacy Law

As an expert in the field, Baer Law covers a variety of Pharmaceutical Law services ranging from Federal & State Regulatory Issues to FDA Compliance and Drug Compounding. 

Read More >

MedicalIcon

Health Care Law

Baer Law focuses on a variety of health care law services ranging from Telemedicine / Telepharmacy and HIPAA Compliance to Professional Board Actions.

Read More >

Client Testimonial

"I want to thank you again for all you have done for me.   I cannot express my gratitude to you and the time and effort you put into my case.   You truly care and I wanted to thank you again for everything."

FDA Preparing a List of Bulk Drug Substances for Compound Drug Products

The Food and Drug Administration (FDA) is preparing a list of bulk drug substances that outsourcing facilities may use to compound drug products in accordance with Section 503B of the Food, Drug and Cosmetic Act (FDC Act).  Requests for electronic and written nominations ended in early March 2014. Section 503B of the FDC Act defines…

Drug Quality and Security Act: Title I – Compounding

On November 23, 2013, the President signed the Drug Quality and Security Act (DQSA) into law. As discussed previously on the Baer Law Blog, the legislation was designed to clarify the Food And Drug Administration’s (FDA) oversight authority over drug compounding and update the federal drug tracking and tracing system. The goal of Title I…

Drug Quality and Security Act: Title II – Track and Trace System

The Drug Quality and Security Act (DQSA) was designed to clarify the Food And Drug Administration’s (FDA) oversight authority over drug compounding and update the federal drug tracking and tracing system. Title II of the DQSA seeks to reduce drug shortages, theft, counterfeiting and drug diversion by modernizing existing federal law and replacing current state…